This hcv division is a disaster

































Not one has mentioned the most important Bombshell that exploded yesterday.

What was it? Is was the fact that Abbvie let Idenix be bought by Merck!!

Why was that important? Because now Abbvies 2nd generation is as obsolete as its first!!

Why is that? Because without a Nuc, your 2nd gen will be a 12 week regimen and not as good as a NUC+PI+NS5A combo.

So Sorry...You guys are done for. FOR CERTAIN!

(Don't count on ACHN...They own zero IP for its one nuc; That means no company will touch it)
 








Not one has mentioned the most important Bombshell that exploded yesterday.

What was it? Is was the fact that Abbvie let Idenix be bought by Merck!!

Why was that important? Because now Abbvies 2nd generation is as obsolete as its first!!

Why is that? Because without a Nuc, your 2nd gen will be a 12 week regimen and not as good as a NUC+PI+NS5A combo.

So Sorry...You guys are done for. FOR CERTAIN!

(Don't count on ACHN...They own zero IP for its one nuc; That means no company will touch it)

What the heck is a NUC? We got a good cure % idiot.

And we work at different sites within the virus.
 












What the heck is a NUC? We got a good cure % idiot.

And we work at different sites within the virus.

Your ignorance speaks volumes. Also the cure rate is very comparable for everyone so spit out that differentiation point's koolaid.
The only prayer AbbVie has to make inroads worth a shit in this market is to essentially price it at bargain basement prices. That will be a very short fix. Docs know you get what you pay for. Its a Merck and Gilly game now. Period.
 








Your ignorance speaks volumes. Also the cure rate is very comparable for everyone so spit out that differentiation point's koolaid.
The only prayer AbbVie has to make inroads worth a shit in this market is to essentially price it at bargain basement prices. That will be a very short fix. Docs know you get what you pay for. Its a Merck and Gilly game now. Period.

Exclamation point.
 




Your ignorance speaks volumes. Also the cure rate is very comparable for everyone so spit out that differentiation point's koolaid.
The only prayer AbbVie has to make inroads worth a shit in this market is to essentially price it at bargain basement prices. That will be a very short fix. Docs know you get what you pay for. Its a Merck and Gilly game now. Period.

Ampersand